Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

Virology Journal

Volumn 7, Issue , 2010, Pages

  Jobarteh, Modou ^a   Malfroy, Marine ^a,d   Peterson, Ingrid ^a   Jeng, Adam ^a   Sarge Njie, Ramu ^a   Alabi, Abraham ^a,e   Peterson, Kevin ^a   Cotten, Matt ^a   Hall, Andrew ^b   Rowland Jones, Sarah ^a,f   Whittle, Hilton ^a   Tedder, Richard ^c   Jaye, Assan ^a   Mendy, Maimuna ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CENTRE LÉON BÉRARD   (France)

^e US Department of Defense HIV Program (Nigeria)   (Nigeria)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; LAMIVUDINE; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ENDEMIC DISEASE; FEMALE; GAMBIA; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; VIRUS LOAD; BLOOD; CD4 LYMPHOCYTE COUNT; COMORBIDITY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; RETROSPECTIVE STUDY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DNA, VIRAL; FEMALE; GAMBIA; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77956512818     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-230     Document Type: Article

References (49)

1. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. ST Goldstein F Zhou SC Hadler BP Bell EE Mast HS Margolis, Int J Epidemiol 2005 34 1329 1339 10.1093/ije/dyi206 16249217
2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. D Lavanchy, J Viral Hepat 2004 11 97 107 10.1046/j.1365-2893.2003.00487.x 14996343
3. Cancer burden in the year 2000. The global picture. DM Parkin FI Bray SS Devesa, Eur J Cancer 2001 37 Suppl 8 4 66 10.1016/S0959-8049(01)00267-2 11602373
4. Clinical outcomes after transfusion-associated hepatitis C. MJ Tong NS el-Farra AR Reikes RL Co, N Engl J Med 1995 332 1463 1466 10.1056/ NEJM199506013322202 7739682
5. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. V Paradis P Mathurin M Kollinger F Imbert-Bismut F Charlotte A Piton P Opolon A Holstege T Poynard P Bedossa, J Clin Pathol 1997 50 401 406 10.1136/jcp.50.5.401 9215123 (Pubitemid 27278444)
6. Global surveillance and control of hepatitis C. Report of a WHO consultation organised in collaboration with the Viral Hepatitis Prevention Board. Antwerp, Belgium. WHO, J Viral Hepat Belgium 1999 35 47
7. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. V Madhava C Burgess E Drucker, Lancet Infect Dis 2002 2 293 302 10.1016/S1473-3099(02)00264-5 12062995
8. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. SD Ahmed LE Cuevas BJ Brabin P Kazembe R Broadhead FH Verhoeff CA Hart, J Infect 1998 37 248 251 10.1016/S0163-4453(98)91983-1 9892528
9. [Hepatitis C in tropical areas]. JM Debonne E Nicand JP Boutin D Carre Y Buisson, Med Trop (Mars) 1999 59 508 516 10901856
10. Hepatitis B virus infection in two Gambian villages. HC Whittle AK Bradley K McLauchlan AB Ajdukiewicz CR Howard AJ Zuckerman IA McGregor, Lancet 1983 1 1203 1206 10.1016/S0140-6736(83)92477-7 6133999
11. The pattern of childhood hepatitis B infection in two Gambian villages. HC Whittle H Inskip AK Bradley K McLaughlan F Shenton W Lamb J Eccles BA Baker AJ Hall, J Infect Dis 1990 161 1112 1115 2345294
12. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. GD Kirk OA Lesi M Mendy AO Akano O Sam JJ Goedert P Hainaut AJ Hall H Whittle R Montesano, Hepatology 2004 39 211 219 10.1002/hep.20027 14752840
13. Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia. CI Mboto M Fielder A Davies-Russell AP Jewell, West Afr J Med 2009 28 16 19 19662739
14. -2008 report on the global AIDS epidemic. http://www.unaids.org/en/ KnowledgeCentre/HIVData/GlobalReport/2008/2008-Global-report.asp
15. HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Cote d'Ivoire. K Odehouri KM De Cock JW Krebs J Moreau M Rayfield JB McCormick G Schochetman R Bretton G Bretton D Ouattara P Heroin J-M Kanga B Beda E Niamkey A Kadio E Gariepe WL Heyward, AIDS 1989 3 509 512 10.1097/00002030-198908000-00004 2508711
16. Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention? N Meda I Ndoye S M'Boup A Wade S Ndiaye C Niang F Sarr I Diop M Carael, AIDS 1999 13 1397 1405 10.1097/00002030-199907300-00018 10449294
17. Trends and interaction of HIV-1 and HIV-2 in Guinea- Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. H Norrgren S Andersson AJ Biague ZJ da Silva F Dias A Naucler G Biberfeld, AIDS 1999 13 701 707 10.1097/00002030-199904160-00011 10397565
18. Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia. MF Schim van der Loeff A Hansmann AA Awasana MO Ota D O'Donovan R Sarge-Njie K Ariyoshi P Milligan H Whittle, AIDS 2003 17 2389 2394 10.1097/00002030- 200311070-00015 14571192
19. Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. C Tienen MS van der Loeff SM Zaman T Vincent R Sarge-Njie I Peterson A Leligdowicz A Jaye S Rowland-Jones P Aaby H Whittle, J Acquir Immune Defic Syndr 53 640 647 19841588
20. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). CL Thio EC Seaberg R Skolasky Jr J Phair B Visscher A Munoz DL Thomas, Lancet 2002 360 1921 1926 10.1016/S0140-6736(02) 11913-1 12493258
21. Hepatitis B virus vaccine in The Gambia, West Africa: synergy between public health research and practice. RW Ryder, Mt Sinai J Med 1992 59 487 492 1336128
22. Natural history of chronic hepatitis B in co-infected patients. M Puoti C Torti R Bruno G Filice G Carosi, J Hepatol 2006 44 65 70 10.1016/j.jhep.2005. 11.015 16338021
23. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. N Bodsworth B Donovan BN Nightingale, J Infect Dis 1989 160 577 582 2571646
24. Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. MF Schim van der Loeff R Sarge-Njie S Ceesay AA Awasana P Jaye O Sam KO Jaiteh D Cubitt P Milligan HC Whittle, AIDS 2003 17 1841 1846 10.1097/00002030-200311070-00015 12891071
25. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). H Diop-Ndiaye C Toure-Kane JF Etard G Lo P Diaw NF Ngom-Gueye PM Gueye K Ba-Fall I Ndiaye PS Sow E Delaporte S Mboup, J Med Virol 2008 80 1332 1336 10.1002/jmv.21236 18551596
26. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. S Usuda H Okamoto H Iwanari K Baba F Tsuda Y Miyakawa M Mayumi, J Virol Methods 1999 80 97 112 10.1016/S0166-0934(99)00039-7 10403681
27. Hepatitis B virus status of southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. MC Kew E Rossouw J Hodkinson A Paterson GM Dusheiko JM Whitcutt, Hepatology 1983 3 65 68 10.1002/hep.1840030110 6295908
28. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. F Rouet ML Chaix A Inwoley P Msellati I Viho P Combe V Leroy F Dabis C Rouzioux, J Med Virol 2004 74 34 40 10.1002/jmv.20143 15258966
29. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. E Collenberg T Ouedraogo J Ganame H Fickenscher G Kynast-Wolf H Becher B Kouyate HG Krausslich L Sangare DM Tebit, J Med Virol 2006 78 683 692 10.1002/jmv.20593 16555290
30. Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. ME Mendy SJ McConkey MA Sande van der S Crozier S Kaye D Jeffries AJ Hall HC Whittle, Virol J 2008 5 49 10.1186/1743-422X-5-49 18416832
31. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. JF Colin D Cazals-Hatem MA Loriot M Martinot-Peignoux BN Pham A Auperin C Degott JP Benhamou S Erlinger D Valla P Marcellin, Hepatology 1999 29 1306 1310 10.1002/hep.510290447 10094979
32. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. H Oshitani FC Kasolo M Mpabalwani K Mizuta NP Luo H Suzuki Y Numazaki, Trans R Soc Trop Med Hyg 1996 90 235 236 10.1016/S0035-9203(96)90227-8 8758060
33. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. RJ Gilson AE Hawkins MR Beecham E Ross J Waite M Briggs T McNally GE Kelly RS Tedder IV Weller, AIDS 1997 11 597 606 10.1097/00002030-199705000-00007 9108941
34. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. MJ Mphahlele A Lukhwareni RJ Burnett LM Moropeng JM Ngobeni, J Clin Virol 2006 35 14 20 10.1016/j.jcv.2005.04.003 15916918
35. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. ME Mendy T Welzel OA Lesi P Hainaut AJ Hall MH Kuniholm S McConkey JJ Goedert S Kaye S Rowland-Jones H Whittle GD Kirk, J Viral Hepat 2010 17 2 115 22 10.1111/j.1365-2893.2009.01168.x 19874478
36. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. MF Yuen Y Tanaka DY Fong J Fung DK Wong JC Yuen DY But AO Chan BC Wong M Mizokami CL Lai, J Hepatol 2009 50 80 88 10.1016/j.jhep.2008.07.023 18977053
37. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. GB Gaeta G Stornaiuolo DF Precone S Lobello M Chiaramonte T Stroffolini G Colucci M Rizzetto, J Hepatol 2003 39 1036 1041 10.1016/S0168-8278(03)00470-7 14642623
38. Occult hepatitis B virus infection and its clinical implications. KQ Hu, J Viral Hepat 2002 9 243 257 10.1046/j.1365-2893.2002.00344.x 12081601
39. -20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. S Viviani P Carrieri E Bah AJ Hall GD Kirk M Mendy R Montesano A Plymoth O Sam M Van der Sande H Whittle P Hainaut, Cancer Epidemiol Biomarkers Prev 2008 17 3216 3223 10.1158/1055-9965.EPI-08-0303 18990765
40. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). A Ruggieri C Argentini F Kouruma P Chionne E D'Ugo E Spada S Dettori S Sabbatani M Rapicetta, J Gen Virol 1996 77 Pt 9 2073 2076 10.1099/0022-1317-77-9-2073 8811005
41. Hepatitis C virus infection in Guinea-bissau: a sexually transmitted genotype 2 with parenteral amplification? M Plamondon AC Labbe E Frost S Deslandes AC Alves N Bastien J Pepin, PLoS One 2007 2 372 10.1371/journal.pone. 0000372 17440608
42. Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. R Kesli M Ozdemir MG Kurtoglu M Baykan B Baysal, J Int Med Res 2009 37 1420 1429 19930846
43. Towards a better understanding of the epidemiology of HIV-2. MF Schim van der Loeff P Aaby, AIDS 1999 13 Suppl A 69 84 10885765
44. National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. JM Garcia-Calleja E Gouws PD Ghys, Sex Transm Infect 2006 82 Suppl 3 ii64 70 10.1136/sti.2006.019901 16735296
45. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. SH Wang SH Yeh WH Lin HY Wang DS Chen PJ Chen, Hepatology 2009 50 1392 1402 10.1002/hep.23163 19670412
46. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. MF van der Loeff AA Awasana R Sarge-Njie M van der Sande A Jaye S Sabally T Corrah SJ McConkey HC Whittle, Int J Epidemiol 2006 35 1322 1328 10.1093/ije/dyl037 16543363
47. Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau. S Jallow T Vincent A Leligdowicz T De Silva C Van Tienen A Alabi R Sarge-Njie P Aaby T Corrah H Whittle A Jaye G Vanham S Rowland-Jones W Janssens, Clin Infect Dis 2009 48 1790 1793 10.1086/599107 19438401
48. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. ME Mendy S Kaye M van der Sande P Rayco-Solon PA Waight D Shipton D Awi P Snell H Whittle SJ McConkey, Virol J 2006 3 23 10.1186/1743-422X-3-23 16594999
49. Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. MI Gismondi LH Staendner S Grinstein CA Guzman MV Preciado, J Clin Microbiol 2004 42 1298 1301 10.1128/JCM.42.3.1298-1301.2004 15004102